Dr. Mehmet Oz, Trump’s administrator for the Centers for Medicare & Medicaid Services, held a press conference regarding the president’s announcement of his weight-loss drug cost-reduction plan when the incident occurred.

Executives from Novo Nordisk, which makes Ozempic, Rybelsus, and Wegovy, were present. White House Press Secretary Karoline Leavitt later stated that the person was doing “okay” after the fainting.

“The White House Medical Unit quickly jumped into action, and the gentleman is okay,” she said.

At first, it was reported that Gordon Findlay, an executive at Novo Nordisk, had passed out. However, the company said that CEO Mike Doustdar and Dave Moore, EVP, US Operations, were the only two Novo Nordisk reps in the room. Later, it was confirmed that the guest was from Eli Lilly, a pharmaceutical company.

“If you’ve ever been in the Oval Office, you stand a long